Norbert G Riedel Jazz Pharmaceuticals PLC (JAZZ) insider trading activity

Norbert G Riedel is Director of Jazz Pharmaceuticals plc. Currently has a direct ownership of 7,024 shares of JAZZ, which is worth approximately $796,029. The most recent transaction as insider was on Aug 08, 2025, when has been sold 1,805 shares (Ordinary Shares) at a price of $111.25 per share, resulting in proceeds of $200,806. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.02K

31.98% 3M change

31.98% 12M change

Total Value Held $796,029

NORBERT G RIEDEL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 08 2025	SELL Payment of exercise price or tax liability	$200,806 $111.25 p/Share	1,805 Reduced 20.44%	7,024 Ordinary Shares
Aug 07 2025	BUY Grant, award, or other acquisition	-	3,507 Added 28.43%	8,829 Ordinary Shares
Aug 06 2024	SELL Payment of exercise price or tax liability	$165,243 $111.35 p/Share	1,484 Reduced 21.8%	5,322 Ordinary Shares
Aug 02 2024	BUY Grant, award, or other acquisition	-	3,731 Added 35.41%	6,806 Ordinary Shares
Aug 14 2023	SELL Open market or private sale	$171,456 $138.16 p/Share	1,241 Reduced 8.3%	13,705 Ordinary Shares
Aug 11 2023	BUY Grant, award, or other acquisition	-	3,075 Added 17.06%	14,946 Ordinary Shares
Aug 08 2022	SELL Open market or private sale	$165,876 $152.32 p/Share	1,089 Reduced 8.4%	11,871 Ordinary Shares
Aug 05 2022	SELL Open market or private sale	$1,246,960 $155.87 p/Share	8,000 Reduced 43.48%	10,399 Ordinary Shares
Aug 05 2022	BUY Exercise of conversion of derivative security	$442,240 $55.28 p/Share	8,000 Added 30.3%	18,399 Ordinary Shares
Aug 05 2022	BUY Grant, award, or other acquisition	-	2,561 Added 16.5%	12,960 Ordinary Shares
Aug 06 2021	SELL Open market or private sale	$193,236 $147.96 p/Share	1,306 Reduced 11.16%	10,399 Ordinary Shares
Jul 29 2021	BUY Grant, award, or other acquisition	-	2,246 Added 16.1%	11,705 Ordinary Shares

Also insider at

CERE

Cerevel Therapeutics Holdings, Inc. Healthcare

APTX

Aptinyx Inc. Healthcare

EXECUTIVE CHAIRMAN OF THE BOD

ETON

Eton Pharmaceuticals, Inc. Healthcare

Director

NGR

Norbert G Riedel

Director

Dublin 4, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAZZ shares.

Notify only if

Value

Insider Trading

Get notified when an Jazz Pharmaceuticals PLC insider buys or sells JAZZ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jazz Pharmaceuticals plc

Track Activities on JAZZ

Account